MYC and malignant colon neoplasm: Notably, c-Myc is amplified in colon cancer, and polyamine and c-Myc are known to promote colorectal cancer cell survival [68], suggesting that targeting polyamine and c-Myc may contribute to BRAFi resistance in colon cancer.